Migraine

Emergency department treatment for severe headache usually means a prescription for painkillers. But a Minnesota doctor has come up with a non-prescription, low-tech way of treating severe headache pain-immersing the back of the patient's head in a basin of gradually cooling water.

Patients who underwent non-endoscopic trigger deactivation and cosmetic eyelid surgery reported an improvement in their migraines.

Although variouis contraceptives are available for women whose baseline health is good, women who have chronic medical conditions have unique concerns.

The frequency of migraine headaches is greater among perimenopausal and early menopausal women than their premenopausal counterparts.

Many patients with multiple sclerosis have numerous comorbid chronic conditions that worsen mental health and increase mortality.

When the breasts are disproportionate to the rest of a woman's body, physical and psychological side effects can become very real issues.

Although many migraine sufferers can abort their headaches with over-the-counter remedies, a significant percentage of patients require prescription medication for relief.

A recent review found that tonabersat, a novel benzoylamino benzopyran compound, is well-tolerated, but no better than placebo for migraine prophylaxis.

By blocking a key pain receptor in mice models, a team of researchers has discovered a potential new method for treating obesity and diabetes.

Concussions that do not heal within 7-10-days may be associated with psychiatric disorders.

The expanded use of biofeedback can provide multiple benefits for patients who report issues ranging from headaches to neck pain and muscle tension.

Results of 2 new studies suggest humanized anti-calcitonin gene-related peptide antibodies may be safe and effective as treatments to prevent migraines in patients with a high monthly frequency of migraines.

By paralyzing the facial muscles involved in producing frown lines, onabotulinumtoxinA injection seems to alleviate depression, especially among patients who exhibit a high degree of hyperactivity.

Teasing out relevant the relationship among risk factors, comorbidities, and migraine is challenging but critical for optimal migraine treatment.

For many migraine sufferers, current strategies to treat headaches, or to prevent their occurrence, are insufficient to ward off the near-daily occurrence of head pain, prompting researchers to investigate methods of pre-emptive migraine treatment.

The clinical challenge of accurate headache diagnosis in the office can be overcome by taking a broad view of the various diagnostic categories of headache.

Two new agents using a novel mechanism of action for the prevention of migraine headaches are the subject of interest after phase 2 studies of the drugs showed promising results.

Although the benefit of Botox (onabotulinumtoxinA) for preventing headaches in adults with chronic migraine has been extensively established in clinical trials, limited data exists on the injections' effectiveness for the indication beyond 5 treatment cycles.

Data from two studies involving drugs that target the calcitonin gene-related peptide for migraine prevention will be released at the 2014 AAN annual meeting.

Clinical trial data show Topamax (topiramate) safely and effectively reduces the frequency of migraine in adolescents compared to placebo.

Morbidly or severely obese individuals develop migraine disorders significantly more often than patients who carry less weight.

The US Food and Drug Administration has approved Cefaly, the first device for use as a preventive treatment for migraine headache.

Although they have all participated in the development of treatment guidelines for a variety of pain conditions, 3 comprehensive pain experts openly acknowledged and discussed the practical limitations of published evidence-based recommendations during the closing session of the American Academy of Pain Medicine 2014 Annual Meeting.

A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).

The US Food and Drug Administration (FDA) has approved the first device to ease the pain of migraines preceded by aura.

A new report from the Institute of Medicine (IOM) calls for a national surveillance program that will help create enough data on concussions in young athletes to counter the lack of information on the phenomenon, as well as resist what the agency calls "a culture of resistance" pervading youth sports.

Teens who reported chronic headache months after having concussions may have been taking too much pain medication, a new study suggests.

People with migraines are at twice the risk of depression as people without migraine headaches, particularly those under age 30, according to a new Canadian study.

Despite current guideline recommendations against the use of routine neuroimaging for uncomplicated headaches, physicians still tend to order imaging tests for many patients who present with headache and migraine, driving up annual healthcare spending.

Study results show that a structured educational intervention for staff aimed at improving knowledge of pain assessment and treatment has little effect on outcomes as measured by pain scores.